Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_870c6e68c09f6b820fc9b7fefe1a56fc |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-021 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
filingDate |
2016-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35ead63c29a096ae7337e3aa8a649f91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09abc6a6c63f8937c44caffc0b1f5da1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f7b79eb63745fc1765ea8ab6d7b02b4 |
publicationDate |
2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018110217-A1 |
titleOfInvention |
In Vitro Preservation of Therapeutic Cells |
abstract |
The invention concerns in vitro preservation of living animal cells. In particular, the invention provides a method for in vitro preservation of cells comprising maintaining adherent mesenchymal stem cells (MSC) or adherent MSC-derived cells in suspension in a composition comprising at least 20% v/v human plasma or human serum or a mixture thereof. |
priorityDate |
2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |